| ²é¿´: 278 | »Ø¸´: 1 | ||
ltx0744624½ð³æ (СÓÐÃûÆø)
|
[ÇóÖú]
΢Æ×Êý¾ÝÇóÖú
|
|
13C NMR ÈܼÁ ë®´ú±ûͪ 56.7,70.5,102.1,108.2,109.0,116.5,117.6,128.5,132.8,143.1,147.3,148.0,165.5,174.0 |
» ²ÂÄãϲ»¶
288»·¾³×¨Ë¶,Çóµ÷²ÄÁÏ·½Ïò
ÒѾÓÐ39È˻ظ´
353Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
Ò»Ö¾Ô¸211µç×ÓÐÅÏ¢347Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
323Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
285Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
Ò»Ö¾Ô¸211£¬»¯Ñ§Ñ§Ë¶£¬310·Ö£¬±¾¿ÆÖصãË«·Ç£¬Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
22408 266Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
313Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
305Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ11È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
JYN-33 ΢Æ×ÇóÖú£¬¼±Çó£¬Ð»Ð»£¬×·¼Ó½ð±Ò¡£¡£¡£
ÒѾÓÐ6È˻ظ´
ÇóÖú΢Æ×Êý¾Ý²éѯ
ÒѾÓÐ5È˻ظ´
ÇóÖú΢Æ×Êý¾Ý²éѯ
ÒѾÓÐ3È˻ظ´
ÇóÖú΢Æ×Êý¾Ý²éѯ
ÒѾÓÐ4È˻ظ´
ÇóÖú΢Æ×Êý¾Ý²éѯ
ÒѾÓÐ4È˻ظ´
ÇóÖúÁ½¸ö»¯ºÏÎïµÄ΢Æ×Êý¾Ý²éѯ
ÒѾÓÐ3È˻ظ´
ÇóÖúÒ»¸ö»¯ºÏÎïµÄ΢Æ×Êý¾Ý
ÒѾÓÐ4È˻ظ´
΢Æ×Êý¾Ý²éѯÇóÖú
ÒѾÓÐ3È˻ظ´
ÇóÖú΢Æ×Êý¾Ý²éѯ
ÒѾÓÐ4È˻ظ´
΢Æ×Êý¾ÝÇóÖú ¼±±ÏÒµ
ÒѾÓÐ4È˻ظ´
ÇóÖúͨ¹ý΢Æ×²éѯ»¯ºÏÎï½á¹¹
ÒѾÓÐ4È˻ظ´
ÇóÖú΢Æ×Êý¾Ý
ÒѾÓÐ3È˻ظ´
ÇóÖú΢Æ×Êý¾Ý~
ÒѾÓÐ4È˻ظ´
[ÇóÖú]ÄÄλºÃÈËѧУ¿ÉÒÔʹÓÃ΢Æ×Êý¾Ý¿â£¬°ïÎÒ¼ìË÷¼¸¸ö»¯ºÏÎïµÄĸºË¡£Ð»Ð»£¡
ÒѾÓÐ4È˻ظ´

wangwang1989
ÖÁ×ðľ³æ (Ö°Òµ×÷¼Ò)
- Ó¦Öú: 525 (²©Ê¿)
- ½ð±Ò: 11769.2
- É¢½ð: 1451
- ºì»¨: 21
- ɳ·¢: 18
- Ìû×Ó: 4912
- ÔÚÏß: 315.2Сʱ
- ³æºÅ: 1467486
- ×¢²á: 2011-10-30
- רҵ: ÌìȻҩÎﻯѧ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
ltx0744624: ½ð±Ò+20, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸ 2013-07-09 08:06:12
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
ltx0744624: ½ð±Ò+20, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸ 2013-07-09 08:06:12
|
²éѯģʽ£ºÄ£ºý²éѯ ̼Æ×Êý¾ÝÊäÈ룺 °´´ÓСµ½´ó˳ÐòÊäÈ룬Êý×Ö¼äÓÃÓ¢Îİë½Ç¶ººÅ(,)·Ö¸ôÀýÈ磺 21.4,30.4,37.4,73.2,73.7,125.6,126.6,139.6,140.2,168.2 ÈܼÁÑ¡Ï Æ¥ÅäÈݲ (Êý×Ö¸ñʽ£¬¿É×ÔÐÐÉ趨) ÏàËÆ¶È£º %(ÏàËÆ¶È>=50%) ²éѯ½á¹û£º¹²²éµ½157¸ö»¯ºÏÎï(²éѯ½á¹û½ö¹©²Î¿¼) 1 . 4-(4-Fluorobenzyloxy)-2-hydroxybenzoic acid C14H11FO4 ÏàËÆ¶È:57.1% Bioorganic & Medicinal Chemistry 2011 19 4935-4952 Design of HIV-1 integrase inhibitors targeting the catalytic domain as well as its interaction with LEDGF/p75: A scaffold hopping approach using salicylate and catechol groups Xing Fan, Feng-Hua Zhang, Rasha I. Al-Safi, Li-Fan Zeng, Yumna Shabaik, Bikash Debnath, Tino W. Sanchez, Srinivas Odde, Nouri Neamati, Ya-Qiu Long Structure 13C NMR ̼Æ×Ä£Äâͼ 2 . 5-ethoxycarbonyl-6-methyl-4-(4-cyanophenyl)-3.4-dihydro-pyrimidin-2(1H)-thione C15H15N3O2S ÏàËÆ¶È:57.1% Journal of Heterocyclic Chemistry 2010 47 136-146 The development of an ecofriendly procedure for alkaline metal (II) sulfate promoted synthesis of N,N'-dimethyl substituted (unsubstituted)-4-aryl-3,4-dihydropyrimidones (thiones) and corresponding bis-analogues in aqueous medium: Evaluation by green chem Chhanda Mukhopadhyay and Arup Datta Structure 13C NMR ̼Æ×Ä£Äâͼ 3 . 2-Amino-4-benzo[1,3]dioxol-5yl-5-bromo-6-phenyl-pyrimidine ÏàËÆ¶È:57.1% Bioorganic & Medicinal Chemistry 2008 16 2741-2752 A new generation of adenosine receptor antagonists: From di- to trisubstituted aminopyrimidines Jacobus P.D. van Veldhoven, Lisa C.W. Chang, Jacobien K. von Frijtag Drabbe K¨¹nzel, Thea Mulder-Krieger, Regina Struensee-Link, Margot W. Beukers, Johannes Brussee, Adriaan P. Ijzerman Structure 13C NMR ̼Æ×Ä£Äâͼ 4 . 4-Methoxy-6-(11,12-dihydroxystyryl)-2-pyrone ÏàËÆ¶È:57.1% Natural Product Sciences 2010 16 148-152 Microbial Metabolism of Yangonin, a Styryl Lactone from Piper methysticum (Kava) Kim, Ji-Hye; Kim, Hyun-Jung; Lee, Ik-Soo Structure 13C NMR ̼Æ×Ä£Äâͼ 5 . 1-Methoxy-4,9,10,10a-tetrahydrodipyrrolo[2,1-a:4',3',2'-de] isoquinolin-8(6H)-one C14H14N2O2 ÏàËÆ¶È:57.1% Tetrahedron 2012 68 1117-1127 Studies on pyrrolidinones. Synthesis of 4,5-fused-3-hydroxypyridinyl-2-propionic acid derivatives Rufine Aku¨¦-G¨¦du, Daniel Couturier, Jean-Pierre H¨¦nichart, Benoit Rigo, G¨¦rard Sanz, Luc Van Hijfte, Anne Bourry Structure 13C NMR ̼Æ×Ä£Äâͼ 6 . (E)-5-(2-Chloro-4-(4-chloro-2,5-dihydroxyphenyl)but-2-enyl)benzene-1,3-diol C32H26O8Cl4 ÏàËÆ¶È:57.1% Marine Drugs 2012 10 1103-1125 Geographic Variability and Anti-Staphylococcal Activity of the Chrysophaentins and Their Synthetic Fragments Jessica L. Keffer, Jared T. Hammill, John R. Lloyd, Alberto Plaza, Peter Wipf and Carole A. Bewley Structure 13C NMR ̼Æ×Ä£Äâͼ 7 . 2,3-dihydro-5,8,9-trihydroxy-1H-pyrimido[1,2-a]quinoline-1-carboxylic acid ÏàËÆ¶È:57.1% Tetrahedron 1987 43 2261-2272 Pyoverdine type siderophores from pseudonomas fluorescens K. Poppe, K. Taraz, H. Budzikiewicz Structure 13C NMR ̼Æ×Ä£Äâͼ 8 . 4,4'-Dihydroxy-2'-methoxy-chalcone ÏàËÆ¶È:57.1% Journal of the Brazilian Chemical Society 2005 16 1402-1405 Biflavonoids and other Phenolics from Caesalpinia pyramidalis (Fabaceae) Marcus V. Bahia, Jamile B. dos Santos, Juceni P. David and Jorge M. David Structure 13C NMR ̼Æ×Ä£Äâͼ 9 . 3,2',4'-Trihydroxy-4-methoxy-chalcone ÏàËÆ¶È:56.2% Journal of Chinese Pharmaceutical Sciences 2011 20 518-522 Flavonoids from the herb of Bidens pilosa L. Xin Tian,Si-Ziang Zhou,He-Lin Wei,Nan Hu,Zhi Dai,Zhi-Gang Liu,Zheng-Zhou Han,Peng-Fei Tu Structure 13C NMR ̼Æ×Ä£Äâͼ 10 . Compound 1k |

2Â¥2013-07-08 11:19:03














»Ø¸´´ËÂ¥